Injective Protocol (INJ) traded at $7.92 on November 14, 2026, posting a 24-hour gain of 3.60% as buyers pushed the token higher during the session. The move offered some relief after a softer stretch, with the asset still carrying a seven-day decline of 3.26%.
Looking at a broader window, INJ has performed more constructively over the past month, adding 10.19% over the 30-day period. That figure suggests the recent weekly pullback represents a consolidation rather than a reversal of the month's overall trend.
The token's market capitalization stood at $0.79 billion as of the report date, reflecting its position as a mid-tier asset within the broader cryptocurrency market. Trading volume and order-book depth were not provided in the available data.
The combination of a strong monthly return alongside a modest weekly dip illustrates the volatility that remains characteristic of the digital-asset space, with short-term price action frequently diverging from longer-horizon performance figures.



